Last reviewed · How we verify

NCT05841329

Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia

Completed NA Last updated 3 May 2023
What this trial tests

NA trial testing tDCS in Acrophobia in 64 participants. Completed in 15 July 2021.

Timeline
6 August 2020
Primary endpoint
15 July 2021
15 July 2021

Quick facts

Lead sponsorShanghai Mental Health Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment64
Start date6 August 2020
Primary completion15 July 2021
Estimated completion15 July 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai Mental Health Center — full company profile →

Who can join

Adults 18 to 50, any sex, with Acrophobia or Transcranial Direct Current Stimulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to examine whether transcranial direct current stimulation(tDCS) can enhance the effect of virtual reality exposure therapy(VRET) in acrophobia in college students with significant fear of heights. The main question it aims to answer are: • the enhancement of tDCS on the effect of VRET Participants will randomly allocated to tDCS active stimulated group and sham stimulated group and receive VRET.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of tDCS

Trials testing the same drug.

Other Shanghai Mental Health Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05841329.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing